Aa. Nabulsi et al., NO ASSOCIATION OF MENOPAUSE AND HORMONE REPLACEMENT THERAPY WITH CAROTID-ARTERY INTIMA-MEDIA THICKNESS, Circulation, 94(8), 1996, pp. 1857-1863
Background Cardiovascular disease is the major cause of death in older
women. Information on the relation of menopause and hormone replaceme
nt therapy with carotid atherosclerosis is limited. Methods and Result
s We examined cross-sectionally the association of menopausal status,
years since last menstruation, and hormone replacement therapy status
with carotid artery intima-media thickness as determined by B-mode ult
rasound. Female participants (n=5436) in the Atherosclerosis Risk in C
ommunities Study without a history of symptomatic cardiovascular disea
se were included in the analyses. Menopause status in 45- to 54-year-o
ld women who had never used hormone replacement therapy was not strong
ly associated with carotid intima-media thickness (mean=0.65 mm and 0.
67 mm in premenopausal and postmenopausal women, respectively, adjuste
d for age, race, cigarette years of smoking, body mass index, sport in
dex, systolic blood pressure, use of blood pressure medications, drink
ing status, diabetes, and education level). In postmenopausal women ag
ed 55 to 64 years, women with less than or equal to 5 years since last
menstruation had an adjusted average intima-media thickness (0.74 mm)
comparable to those with >5 years since last menstruation (0.75 mm) (
P>.05). Although hormone replacement therapy use was associated with a
more favorable lipid and hemostasis profile than nonuse, its use was
not associated with intima-media thickness in postmenopausal women age
d 55 to 64 years (adjusted average=0.74 mm for current users of estrog
en alone and approximate to 0.75 mm each for current users of estrogen
plus progestin, former users, and never users). Conclusions The data
suggest that the well-known associations of hormone replacement therap
y with reductions in atherosclerotic cardiovascular disease may be att
ributable more to acute physiological effects, such as hemodynamic cha
nges or reduced thrombosis, than to atherosclerosis itself.